Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001086377-13-000002
Filing Date
2013-03-15
Accepted
2013-03-15 18:01:23
Documents
1
Period of Report
2013-03-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 8948
  Complete submission text file 0001086377-13-000002.txt   10363
Mailing Address 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address 4452 BELTWAY DRIVE ADDISON TX 75001 214-905-5145
ULURU INC. (Issuer) CIK: 0001168220 (see all company filings)

EIN.: 412118656 | State of Incorp.: NV | Fiscal Year End: 0913
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ULURU INC. 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address
Wallberg Terrance K (Reporting) CIK: 0001372353 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33618 | Film No.: 13695503